In focus · trending topic

Abeona

17 stories · following the connections

Abeona Therapeutics Announces Upcoming Presentations

By Nasdaq OMXMay 8, 2018, 12:15 PM UTC

Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA

By Nasdaq OMXApr 23, 2018, 12:15 PM UTC

Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease

By Nasdaq OMXApr 20, 2018, 12:15 PM UTC

Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer

By Nasdaq OMXApr 2, 2018, 12:15 PM UTC

Abeona Therapeutics Reports Fourth Quarter 2017 Financial Results and Business Highlights

By Nasdaq OMXMar 16, 2018, 9:10 PM UTC

Abeona Therapeutics Receives FDA Rare Pediatric Disease Designation for ABO-202 Gene Therapy Program in CLN1 Disease

By Nasdaq OMXMar 15, 2018, 12:45 PM UTC

Abeona Therapeutics Announces Upcoming Conference Participation

By Nasdaq OMXFeb 21, 2018, 1:45 PM UTC

Abeona Therapeutics Receives FDA Orphan Drug Designation for ABO-202 Gene Therapy Program in Infantile Batten Disease

By Nasdaq OMXFeb 12, 2018, 1:45 PM UTC